Glenmark most promising in pharma pack: Networth Stock Broking

What are you bets from the pharmaceutical arena?

Prakash Diwan: Pharma of course there is a mixed bag of surprises we had some of the pharma companies which were predominantly operating out of SEZs which have seen a little bit of discounting happen because of the new MAT provision. But specifically to the stories that we are seeing in terms of US FDA approval I think Glenmark is one stock that we particularly like because it has the FDA filing which it has gone ahead. Once that is through with the litigation they will probably have an unlimited they will have at least a decent 6 to 12 months of unlimited competition and that is where they could gain significant momentum into that. Glenmark pharma probably stands out to our knowledge much greater than the other ones.